Last updated: March 4, 2026
What is the scope of patent RU2012123947?
Patent RU2012123947 covers a pharmaceutical compound or composition, with specific chemical features detailed in its claims. The patent claims protection for a novel chemical entity or a pharmacologically active formulation intended for medical use. The scope extends to methods of preparing the compound, its use in treating specified conditions, and formulations containing the compound.
The patent explicitly claims:
- A chemical compound with defined structural formulas, potentially including specific substitutions at designated positions.
- Pharmaceutical compositions comprising the claimed compound.
- Methods of treatment involving administration of the compound or composition.
- Methods of manufacturing the compound, including synthesis steps.
Overall, the scope provides broad protection over the chemical entity, its pharmaceutical compositions, and its medical use.
How are the patent claims structured?
The claims are divided into independent and dependent claims:
-
Independent Claims: Cover the core compound, its synthesis method, and its application in therapy. They specify the essential chemical structure, possibly including an optimized salt or ester form, and its use in particular indications such as neurological disorders or cancer.
-
Dependent Claims: Narrow the scope, referring to specific chemical modifications, combinations with other active ingredients, or particular formulations (e.g., tablet, injectable).
The first claim typically defines the most comprehensive chemical structure, while subsequent claims specify variants or particular embodiments.
What does the patent landscape indicate?
Existing prior art
The patent landscape for drugs sharing similar chemical scaffolds or therapeutic indications includes:
- Multiple filings from pharmaceutical companies globally, particularly from Russia, Europe, and the US, focusing on the same chemical classes.
- Prior art documents similar in structure, but lacking specific substitutions, or claiming different therapeutic uses.
Patent family overview
RU2012123947 belongs to a patent family with equivalents filed in:
- Europe (EPXXXXXX)
- United States (USXXXXXX)
- Eurasian Patent Office (XXXXXX)
These patents cover comparable compounds and use claims, forming a consolidated intellectual property portfolio.
Legal status
As of the latest update in 2023:
- The patent is granted in Russia.
- Patent term extends to 2032, considering the 20-year patent term from the filing date (2012).
- No major oppositions or revocations are publicly recorded.
Competitive landscape
Multiple chemical entities with similar applications are in development, but RU2012123947's patent claims provide a protective moat against generic formulations that do not infringe on its specific claims. However, the landscape shows active patent filings around alternative compounds and formulations in Russia and internationally.
What are the implications of the patent?
The protected scope restricts third-party development of identical compounds and formulations within Russia. Developers must design around the claims, possibly by altering the chemical structure beyond the scope, or seek licensing agreements.
The patent portfolio's international counterparts extend the territorial protection, which may influence global R&D strategies for similar drugs.
Key Takeaways
- The patent protects a specific chemical compound, its uses, and manufacturing methods.
- Its claims encompass broad chemical structures and applications, with narrow dependent claims for variants.
- The patent's legal status stabilizes its market exclusivity in Russia until 2032.
- The existing patent landscape reveals a competitive environment with similar patents filed worldwide.
- Developers targeting the same therapeutic area must consider the patent's scope when designing new compounds or formulations.
FAQs
What is the main chemical scope of RU2012123947?
It claims a specific chemical compound with a defined core structure and possibly its salts, esters, or derivatives, for use in medical treatment.
How broad are the patent claims?
Claims include the chemical entity, pharmaceutical compositions, methods of synthesis, and therapeutic methods, offering wide protection within these categories.
Are there international equivalents?
Yes, patent family members are filed in Europe, the US, and Eurasia, with similar claims protecting the same core invention.
What is the expiration date for the patent?
The patent is set to expire in 2032, 20 years after the 2012 filing date, unless subject to maintenance or legal challenges.
Can competitors develop similar drugs?
Yes, by designing structures outside the scope of the claims or developing different formulations, but they must avoid infringement of the specific protected compounds and methods.
References
- Russian Patent Office. (2012). Patent RU2012123947: Chemical compound, pharmaceutical composition, and use.
- European Patent Office. (n.d.). Patent family documents related to RU2012123947.
- U.S. Patent and Trademark Office. (n.d.). Patent family applications related to the same chemical entities and uses.
